Product image of Ornibel (Ethinylestradiol, Etonogestrel) supplied by GNH India

Ornibel

Active Ingredient:
Ethinylestradiol, Etonogestrel
Origin:
EU

Ornibel (Ethinylestradiol, Etonogestrel)

Ethinylestradiol, the active ingredient in Ornibel, is a combined hormonal contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age. GNH India supplies Ornibel as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Ornibel as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Exeltis Healthcare S.L

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ornibel is a combined hormonal contraceptive that acts on the reproductive endocrine pathway to prevent pregnancy.

  • Contraception: Provides reliable prevention of ovulation and pregnancy when taken as prescribed.
  • Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns.
  • Acne management: Reduces androgen‑related skin lesions in women requiring contraception.

How It Works

  • Ornibel combines ethinylestradiol, a synthetic estrogen, with etonogestrel, a progestogenic agent. The estrogen component stabilizes the endometrial lining while the progestin suppresses the hypothalamic‑pituitary‑gonadal axis, inhibiting the mid‑cycle luteinizing hormone surge and preventing follicular development and ovulation.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like.
  • Breast tenderness: temporary swelling or discomfort.
  • Spotting between periods: light vaginal bleeding.
  • Weight gain: modest increase in body weight.
  • Mood changes: irritability or emotional lability.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clot formation in deep veins.
  • Pulmonary embolism: clot migration to lung vessels.
  • Stroke: cerebrovascular accident due to clot or hemorrhage.
  • Myocardial infarction: heart attack in susceptible individuals.
  • Severe allergic reaction: anaphylaxis or angioedema.
  • Liver dysfunction: jaundice or abnormal liver enzymes.

Precautions & Warnings

Before prescribing Ornibel, consider patient‑specific factors and follow safety guidelines.

  • Smoking status: avoid use in women over 35 who smoke regularly.
  • Cardiovascular risk: assess history of hypertension, thrombosis, or heart disease.
  • Liver function: evaluate for active liver disease or dysfunction.
  • Migraine history: caution in patients with migraine with aura.
  • Medication adherence: ensure consistent daily intake for effectiveness.
  • Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Ornibel may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Antiepileptic enzymes inducers (e.g., carbamazepine, phenytoin): reduce hormonal levels.
  • Rifampicin: markedly decreases contraceptive effectiveness.
  • St. John’s wort: herbal inducer that lowers plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): may increase hormone exposure.
  • Antibiotics (e.g., clarithromycin): potential modest reduction in efficacy.
  • Antidepressants (SSRIs): possible increased risk of mood‑related side effects.

Frequently Asked Questions

Ornibel is indicated as a combined hormonal contraceptive for preventing pregnancy in women of reproductive age. It is also used to help regulate menstrual cycles and may improve acne related to androgen excess when contraception is required.

Ethinylestradiol is a synthetic estrogen that stabilizes the endometrial lining and works with etonogestrel to suppress the hypothalamic‑pituitary‑gonadal axis, preventing the mid‑cycle luteinizing hormone surge that triggers ovulation.

The dosing regimen for Ornibel is determined by the prescribing healthcare professional based on the product’s labeling and the patient’s individual needs. Patients should follow the prescriber’s instructions exactly.

Ornibel is contraindicated during pregnancy because it is intended to prevent conception. Limited data are available for breastfeeding; healthcare providers usually advise caution and may recommend alternative contraception while nursing.

To order Ornibel, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Ornibel contains ethinylestradiol and etonogestrel, a progestin with a favorable bleeding profile and lower androgenic activity compared with some older formulations. Its efficacy and safety are comparable to other FDA‑approved combined oral contraceptives, though individual tolerability may differ.

Ornibel tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Ornibel is taken orally, usually as one tablet daily at the same time each day, following the specific cycle regimen indicated in the product labeling (e.g., 21 active tablets followed by a pill‑free interval).

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe allergic reactions, and liver dysfunction. Patients with cardiovascular risk factors or a history of clotting disorders should be evaluated carefully before use.

Ornibel is contraindicated in women who are pregnant, have known or suspected estrogen‑dependent tumors, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or who smoke cigarettes and are over 35 years of age.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Etonogestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT